Blood filtering for septic shock
Part of Infections clinical trials.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 82 years old.
- You have been diagnosed with septic shock (a severe infection causing dangerously low blood pressure) within the last 24 hours.
- You have signs of widespread inflammation and your organs are starting to fail (high scores on two medical scales).
- You are willing to sign a consent form and follow the study's schedule.
- You have not had blood purification (like dialysis) in the past week, and are not taking strong immune-suppressing drugs or high-dose steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special blood filter (hemoadsorption) for people in septic shock (a severe infection causing very low blood pressure). It aims to see if the filter helps remove harmful substances from the blood and improve recovery.
This trial tests whether a blood filtering treatment called hemoadsorption can help protect blood vessels in people with septic shock. It may be an option for patients who are already on strong blood pressure medications and steroids.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This trial tests a new blood-cleansing device (HemoSystem REBOOT) that may help people with sepsis by removing harmful substances and improving immune function. It is for critically ill patients whose immune systems remain suppressed despite standard sepsis treatment.
This study tests whether therapeutic plasma exchange (a procedure that removes and replaces blood plasma) can improve outcomes in ICU patients with septic shock that is not responding to standard medicines. It may help some people whose infection-related illness is causing failing organs.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.